Company intelligence / Profile preview

Aptagen

Jacobus, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Aptagen offers extensive aptamer development services and proprietary catalog (Apta-Index™), supporting clients in research, diagnostics, drug discovery, and targeted delivery. No direct clinical trial results as primary therapeutic programs are not stated.

Therapeutic areas: Other
Modalities: AptamerSynthetic oligonucleotidePeptide oligonucleotide
Industry: Chemicals & Materials

Partnerships

TriLink Biotechnologies (synthetic oligonucleotide manufacturing partner)IBA Solutions (oligonucleotide synthesis)AptaIT (bioinformatics, sequencing)Tissue For Research (human tissue sourcing for validation)Oligo Factory (oligo supply)

Beyond the preview

Go deeper on Aptagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aptagen.

Explore the full profile